These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 31799464)
1. E and prM proteins of genotype V Japanese encephalitis virus are required for its increased virulence in mice. Tajima S; Shibasaki KI; Taniguchi S; Nakayama E; Maeki T; Lim CK; Saijo M Heliyon; 2019 Nov; 5(11):e02882. PubMed ID: 31799464 [TBL] [Abstract][Full Text] [Related]
2. Virulence and Cross-Protection Conferred by an Attenuated Genotype I-Based Chimeric Japanese Encephalitis Virus Strain Harboring the E Protein of Genotype V in Mice. Xia Q; Zhang Y; Yang Y; Ma X; Guan Z; Zhang J; Li Z; Liu K; Li B; Shao D; Qiu Y; Wei J; Ma Z Microbiol Spectr; 2022 Dec; 10(6):e0199022. PubMed ID: 36301111 [TBL] [Abstract][Full Text] [Related]
3. Amino Acid at Position 166 of NS2A in Japanese Encephalitis Virus (JEV) is Associated with In Vitro Growth Characteristics of JEV. Tajima S; Taniguchi S; Nakayama E; Maeki T; Inagaki T; Lim CK; Saijo M Viruses; 2020 Jun; 12(7):. PubMed ID: 32629892 [TBL] [Abstract][Full Text] [Related]
4. In vitro growth, pathogenicity and serological characteristics of the Japanese encephalitis virus genotype V Muar strain. Tajima S; Yagasaki K; Kotaki A; Tomikawa T; Nakayama E; Moi ML; Lim CK; Saijo M; Kurane I; Takasaki T J Gen Virol; 2015 Sep; 96(9):2661-2669. PubMed ID: 26048886 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and Protective Ability of Genotype I-Based Recombinant Japanese Encephalitis Virus (JEV) with Attenuation Mutations in E Protein against Genotype V JEV. Tajima S; Taniguchi S; Nakayama E; Maeki T; Inagaki T; Saijo M; Lim CK Vaccines (Basel); 2021 Sep; 9(10):. PubMed ID: 34696184 [TBL] [Abstract][Full Text] [Related]
6. Growth, Pathogenesis, and Serological Characteristics of the Japanese Encephalitis Virus Genotype IV Recent Strain 19CxBa-83-Cv. Tajima S; Maeki T; Nakayama E; Faizah AN; Kobayashi D; Isawa H; Maekawa Y; Bendryman SS; Mulyatno KC; Rohmah EA; Mori Y; Sawabe K; Ebihara H; Lim CK Viruses; 2023 Jan; 15(1):. PubMed ID: 36680278 [TBL] [Abstract][Full Text] [Related]
7. Construction and immune efficacy of recombinant pseudorabies virus expressing PrM-E proteins of Japanese encephalitis virus genotype І. Qian P; Zhi X; Wang B; Zhang H; Chen H; Li X Virol J; 2015 Dec; 12():214. PubMed ID: 26651827 [TBL] [Abstract][Full Text] [Related]
8. Effects of the Japanese Encephalitis Virus Genotype V-Derived Sub-Viral Particles on the Immunogenicity of the Vaccine Characterized by a Novel Virus-Like Particle-Based Assay. Honjo S; Masuda M; Ishikawa T Vaccines (Basel); 2019 Aug; 7(3):. PubMed ID: 31382680 [TBL] [Abstract][Full Text] [Related]
9. Characterization of a Small Plaque Variant Derived from Genotype V Japanese Encephalitis Virus Clinical Isolate K15P38. Kim WJ; Lee AR; Hong SY; Kim SH; Kim JD; Kim SJ; Oh JS; Shim SM; Seo SU J Microbiol Biotechnol; 2024 Aug; 34(8):1592-1598. PubMed ID: 39081248 [TBL] [Abstract][Full Text] [Related]
10. Emerging Japanese Encephalitis Virus Genotype V in Republic of Korea. Lee AR; Song JM; Seo SU J Microbiol Biotechnol; 2022 Aug; 32(8):955-959. PubMed ID: 35879275 [TBL] [Abstract][Full Text] [Related]
11. An amino acid substitution (V3I) in the Japanese encephalitis virus NS4A protein increases its virulence in mice, but not its growth rate in vitro. Yamaguchi Y; Nukui Y; Tajima S; Nerome R; Kato F; Watanabe H; Takasaki T; Kurane I J Gen Virol; 2011 Jul; 92(Pt 7):1601-1606. PubMed ID: 21411676 [TBL] [Abstract][Full Text] [Related]
12. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice. Gromowski GD; Firestone CY; Whitehead SS J Virol; 2015 Jun; 89(12):6328-37. PubMed ID: 25855730 [TBL] [Abstract][Full Text] [Related]
13. A Japanese encephalitis virus genotype 5 molecular clone is highly neuropathogenic in a mouse model: impact of the structural protein region on virulence. de Wispelaere M; Frenkiel MP; Desprès P J Virol; 2015 Jun; 89(11):5862-75. PubMed ID: 25787283 [TBL] [Abstract][Full Text] [Related]
14. Novel reverse genetics of genotype I and III Japanese encephalitis viruses assembled through transformation associated recombination in yeast: The reporter viruses expressing a green fluorescent protein for the antiviral screening assay. Li C; Chen X; Zhou Y; Hu J; Wang X; Li Y Antiviral Res; 2022 Jan; 197():105233. PubMed ID: 34973281 [TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of chimeric Tembusu viruses containing pre-membrane and envelope genes of Japanese encephalitis virus. Xu B; Liu X; Yan D; Teng Q; Yuan C; Zhang Z; Liu Q; Li Z Front Microbiol; 2023; 14():1140141. PubMed ID: 37426013 [TBL] [Abstract][Full Text] [Related]
16. Characterization of a serine-to-asparagine substitution at position 123 in the Japanese encephalitis virus E protein. Yamaguchi Y; Nukui Y; Kotaki A; Sawabe K; Saijo M; Watanabe H; Kurane I; Takasaki T; Tajima S J Gen Virol; 2013 Jan; 94(Pt 1):90-96. PubMed ID: 23052392 [TBL] [Abstract][Full Text] [Related]
18. Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection. Pugachev KV; Mason PW; Shope RE; Frey TK Virology; 1995 Oct; 212(2):587-94. PubMed ID: 7571428 [TBL] [Abstract][Full Text] [Related]
19. Chimeric Japanese Encephalitis Virus SA14/SA14-14-2 Was Virulence Attenuated and Protected the Challenge of Wild-Type Strain SA14. Huang R; Leng S; Feng Y; Tang L; Yuan L; Yang J Can J Infect Dis Med Microbiol; 2019; 2019():9179308. PubMed ID: 30944684 [TBL] [Abstract][Full Text] [Related]
20. A single mutation in the Japanese encephalitis virus E protein (S123R) increases its growth rate in mouse neuroblastoma cells and its pathogenicity in mice. Tajima S; Nerome R; Nukui Y; Kato F; Takasaki T; Kurane I Virology; 2010 Jan; 396(2):298-304. PubMed ID: 19913862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]